Alicia Carter, MD

Dr Carter is board certified in anatomic and clinical pathology and cytopathology. She earned her medical degree at the University of North Carolina at Chapel Hill, where she also completed her residency and fellowship training.

During her tenure at Labcorp, she has participated in the Scientific Management and Strategic Committee and several Business Advisory Teams, where she has been involved in reviewing the competitive and breakthrough strategies and planning for cytology and women’s health issues.

Alex Katayev, MD

Dr Katayev earned his medical degree at the Leningrad Institute of Medicine and Hygiene, Leningrad, Russia. He completed his residency in dermatology and sexually transmitted diseases at Svetogorsk Regional Hospital, Leningrad, Russia in 1983. He completed his residency in Dermatology and Sexually transmitted Diseases at Leningrad Regional Hospital. Dr Katayev joined Labcorp in 1994, moved to Science & Technology in 2007 and serves as Labcorp’s director of clinical science assessment in the Department of Science and Technology.

LabCorp to Announce Second Quarter Financial Results on July 25, 2019

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 25, 2019-- LabCorp® (NYSE: LH) will release its second quarter of 2019 financial results before the market opens on Thursday, July 25, 2019 , followed by a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

LabCorp and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence

Philips IntelliSite Pathology Solution will be deployed across the Mount Sinai Health System to support greater efficiency and help improve patient care BURLINGTON, N.C. & NEW YORK & AMSTERDAM--(BUSINESS WIRE)--Jun. 18, 2019-- LabCorp® (NYSE: LH) and the Mount Sinai Health System today announced